Pune, 05, Dec 2022: Maximize Market Research has forecast the Intracranial Aneurysm Market to be worth USD 2.5 billion by 2029, with a 9.5 percent CAGR. MicroVention Inc. (Terumo Corporation), B. Braun, Stryker, Medtronic, Johnson and Johnson Services Inc., Microport Scientific Corporation, and Codman Neuro are among the top intracranial aneurysm market players.
Intracranial Aneurysm Market Scope and Research Methodology
The report on the intracranial aneurysm market investigates current market trends and highlights to help clients explore opportunities and develop market strategies. The goods and services, revenue, financial status, portfolio, growth strategies, and regional presence of key market participants and new entrants are all investigated. Recent acquisitions and mergers, as well as company strategic stances and joint alliance information, paint a clear picture of the Intracranial Aneurysm Market’s competitive landscape. A segment-by-segment analysis by Type and End-use is performed to comprehend the products and services of the Intracranial Aneurysm Market, complete with market-influencing factors and current technological changes and innovations. The report also goes into great detail about the Intracranial Aneurysm Market’s drivers, challenges, restraints, and challenges. Market participants and new entrants can use regional market analysis to develop pricing and marketing strategies at the local, regional, and global levels.
The bottom-up approach was used for market estimation and global market trend analysis. To obtain accurate inferences, data was collected from a large sample using both primary and secondary research methods. Surveys, questionnaire distribution, and phone interviews with industry experts, market leaders, entrepreneurs, and marketing professionals were among the primary methods employed. Secondary data was meticulously gathered from a carefully selected set of sources to ensure the accuracy of the conclusions. Official databases of various organizations and government websites, industry journals, white papers, annual reports, product manufacturer and supplier releases, and paid databases are just a few examples. PESTLE was used to understand various market factors, while SWOT analysis was used to understand key companies’ strengths and weaknesses. As a result, the report provides a thorough examination of the Intracranial Aneurysm Market.
For critical insights on this market, request for methodology here @ https://www.maximizemarketresearch.com/request-sample/165000
Intracranial Aneurysm Market Overview
A cerebral or intracranial aneurysm is a brain aneurysm caused by a weakness of a blood vessel wall’s inner muscular layer (the intima). Intracranial aneurysms account for about 4 percent of all cases. Unruptured aneurysms may cause symptoms due to a mass effect, but the real danger occurs when an aneurysm ruptures, resulting in a subarachnoid hemorrhage.
The majority of aneurysms are asymptomatic and will not rupture; however, they grow in unpredictable ways, and even small aneurysms can rupture. Intracranial aneurysms are diagnosed and monitored using imaging techniques such as intra-arterial digital subtraction angiography, computed tomography angiography, magnetic resonance angiography, and, more recently, transcranial Doppler ultrasonography. These treatments have grown in popularity among consumers in recent years, contributing to the growth of the Intracranial Aneurysm market. Furthermore, treatment options include observation, endovascular coiling, and surgical clipping.
Intracranial Aneurysm Market Dynamics
Aneurysms of the cerebral blood vessels are common. In a recent systematic review of data from many different countries, the prevalence was reported to be 0.4 percent in retrospective and 3.6 percent in prospective autopsy studies, and 3.7 percent and 6.0 percent in retrospective and prospective angiographic studies, respectively. The true prevalence in the retrospective autopsy studies is likely to be underestimated because they were unable to review the original data, whereas the angiographic studies are likely to be overestimated due to selection bias. 85 percent of saccular aneurysms of the cerebral vasculature are located in the Willis circle. Multiple aneurysms affect 30 percent of patients. The majority are minor and asymptomatic, but 30,000 people in the United States experience a rupture each year, with a peak in the sixth decade. An intracranial aneurysm rupture results in a parenchymal hemorrhage or, more commonly, a subarachnoid hemorrhage from one that bleeds into the subarachnoid space.
The market for intracranial aneurysms is being driven by an increase in the number of patients suffering from high blood pressure and blood vessel trauma. Hypertension significantly increases the risk of a brain aneurysm and other diseases. As a result of high blood pressure and smoking, a large proportion of the population is currently at risk of developing brain aneurysms. According to WHO facts 2019, hypertension affects approximately 1.13 billion people worldwide. Furthermore, the global population is rapidly aging.
Intracranial Aneurysm Market Regional Insights
North America dominated the intracranial aneurysm market in 2021, accounting for 30.2 percent of total revenue. Because of the availability of well-established healthcare facilities, a growing elderly population, and a high incidence of hypertension and stroke, Furthermore, an increase in the prevalence of intracranial aneurysms and an increase in demand for minimally invasive procedures are driving market growth in the region. Furthermore, a growing number of initiatives launched by various organizations are expected to fuel market growth. The Bee Foundation (TBF), for example, is a non-profit organization dedicated to increasing awareness and lowering the number of deaths caused by cerebral aneurysms through innovative research. The TBF is looking for proposals for a brain aneurysm research grant to help the organization achieve its goal of lowering brain aneurysm mortality.
Intracranial Aneurysm Market Segmentation
- Surgical Clipping
- Endovascular Coiling
- Flow Diverters
Intracranial Aneurysm Market Key Competitors:
- B. Braun Melsungen AG
- MicroPort Scientific Corporation
- Terumo Corporation
- Integra LifeSciences Corporation
- Johnson & Johnson
- RAUMEDIC AG
- Microvention Inc.
- Codman Neuro (Integra Lifesciences)
- AbbVie Inc.
- Amneal Pharmaceuticals Inc.
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche Ltd
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical
- UCB SA
- Biogen Inc.
Key questions answered in the Intracranial Aneurysm Market are:
- What is an Intracranial Aneurysm?
- What is the growth rate of the Intracranial Aneurysm Market over the forecast period?
- What is the nature of competition in the Intracranial Aneurysm industry in developed economies and developing economies?
- Who are the key players in the Intracranial Aneurysm Market?
- Who are the market leaders in Intracranial Aneurysms in Europe?
- Who are the market leaders in Intracranial Aneurysms in USA and Canada?
- Who are the market leaders in Intracranial Aneurysms in India, China, Japan, and South Korea?
- What are the factors affecting growth in the Intracranial Aneurysm Market?
- Who held the largest market share in the Intracranial Aneurysm Market?
- What are the factors for the growth of the Asia-Pacific region in the Intracranial Aneurysm Market?
To remain ‘ahead’ of your competitors, request for a sample @ https://www.maximizemarketresearch.com/request-sample/165000
- Market Share, Size & Forecast by Revenue | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
- Market Segmentation – A detailed analysis by Segment and Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Maximize Market Research is leading research firm, has also published the following reports:
Epilepsy Treatment Market– The Epilepsy Treatment Market size is expected to reach USD 6.57 billion by 2029 at a CAGR of 7.3 percent during the forecast period. The Epilepsy Treatment Market is expected to be driven by an Increase in the Number of Seizures among Patients.
Dementia Treatment Market – The Dementia Treatment Market size is expected to reach USD 26.13 billion by 2029 at a CAGR of 8.32 percent during the forecast period. The Dementia Treatment Market is expected to be driven by an increase in R&D expenditure.
Nerve Repair and Regeneration Market– The Nerve Repair and Regeneration Market size are expected to reach USD 16.5 billion by 2029 at a CAGR of 13 percent during the forecast period. The Nerve Repair and Regeneration Market are expected to be driven by a High Incidence of nerve injuries.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
Company Name: MAXIMIZE MARKET RESEARCH PVT. LTD.
Contact Person: Geeta Yevle
Email: Send Email
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,